Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications looks at the impact of delays in the introduction of value-based procurement.
Fiona Maini, senior director global compliance and strategy at Medidata, a Dassault Systèmes company, outlines the challenges that regulation has with keeping up with technology in 2024.
Ed Turtle and Anushi Amin, associates at law firm Cooley, analyse the new Product Liability Directive which will enter into force in 2024 and apply from 2026.
Elaine Gemmell, head of regulatory affairs at InnoScot Health, analyses where the new EU AI Act legislation is beneficial and where it must remain flexible.
Ravi Subramaniam, director, Conformity Assessment for IEEE SA, outlines the IEEE’s new standards for wireless medical devices in response to the FDA refusing to accept medical devices and associated systems due to cybersecurity concerns.
Sidley Austin’s Josefine Sommer, partner specialising in food, drug and medical device regulation, and Michelle Gandolfo, managing associate, outlines how new European battery regulations may impact medical device manufacturers in the UK.
Jonathan Ripley, IVD and MD consulting services director at IMed Consultancy discusses the role of IVDs, regulatory perspectives for their adoption and increased market access.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications looks at the potential effects of value-based procurement.
Claire Ryan, global head of QA/RA, Joanne Cross, director of marketing and Jennifer Golding, product manager at Yourgene Health discuss the in vitro diagnostic regulatory landscape in Europe and how the ongoing changes will help improve safety.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, looks at the background of what could be the next team of health and social care ministers.
